111C Peiper, Stephen C. - Thomas Jefferson University - Thomas Jefferson University
scp003

Stephen C. Peiper, MD

Contact Dr. Peiper

1020 Locust Street
Jefferson Alumni Hall, Suite 279
Philadelphia, PA 19107

(215) 955-5060
(215) 955-5058 fax

Most Recent Peer-reviewed Publications

  1. Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases
  2. Aberrant expression of CD56 on granulocytes and monocytes in myeloproliferative neoplasm
  3. Characterization of the receptor binding residues of kisspeptins by positional scanning using peptide photoaffinity probes
  4. Enhanced T Cell Lymphoma in NOD.Stat5b Transgenic Mice Is Caused by Hyperactivation of Stat5b in CD8+ Thymocytes
  5. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis
  6. Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model
  7. Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells
  8. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma
  9. Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells
  10. Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists
  11. The metastasis suppressor KISS1 lacks antimetastatic activity in the C8161.9 xenograft model of melanoma
  12. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling
  13. Role and mechanism of arsenic in regulating angiogenesis
  14. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue
  15. Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists
  16. Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH
  17. Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4
  18. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: The exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids
  19. Development of chemokine receptor cxcr4 antagonists using bio-mimetic strategy
  20. Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis
0